The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Cannabidiol within the range consumers are taking with unregulated products linked to increase in liver enzymes ...

Even more concerning? The loss of data. The US funded most HIV tracking systems in Africa, and many have now stopped collecting patient and hospital records.

The USPSTF meets several times a year to review the latest science and decide which screenings, medications and other preventive services should be fully covered by insurance.

However, childhood cancer survivors have lower risk for registered COVID-19 infection relative to comparators.

Introduction of immune checkpoint inhibitors linked to widening disparity for those with private insurance versus those without insurance.

HealthDay News — For adults with chronic low back pain, gabapentin prescription is associated with an increased risk for dementia and mild cognitive impairment (MCI), according to a study published ...

The FDA is expected to decide on treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis.

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

Lawsuit filed against RFK Jr over vaccine policy changes; oral on-demand treatment approved for HAE; OTC cuffless blood pressure monitor gets greenlit; ...

Unfortunately, Dr Monarez, who has served as Trump’s acting CDC director, has done nothing to stand in the way” of Kennedy’s actions, said Sen. Bernie Sanders.

HealthDay News — The US Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as replies to drug and biological product applications submitted ...